Trulieve Cannabis Corp. 10-Q Summary: Q2 2025
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2025. Trulieve Cannabis Corp. is a vertically integrated, multi-state cannabis operator with retail and cultivation facilities in nine U.S. states. As of the reporting date, the company operated 231 dispensaries and 15 cultivation/processing facilities. The company is classified as a large accelerated filer.
Key Financial Metrics
| Metric (in thousands) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Revenue | $302,086 | $303,442 | $599,846 | $601,061 |
| Gross Profit | $182,926 | $181,648 | $366,145 | $355,450 |
| Gross Margin | 60.6% | 59.9% | 61.0% | 59.1% |
| Net Loss (GAAP) | $(16,111) | $(12,312) | $(49,870) | $(37,159) |
| Adjusted EBITDA | $110,613 | $106,957 | $219,803 | $212,752 |
| Cash & Equivalents | $392,580 | $238,803 | $392,580 | $238,803 |
| Operating Cash Flow (YTD) | $136,831 | $210,472 | $136,831 | $210,472 |
| Total Debt (Long-Term) | $612,914 | $612,306 | $612,914 | $612,306 |
Note: Total Debt includes Private Placement Notes ($365.7M), Notes Payable ($108.5M), and Construction Finance Liabilities ($134.7M) as of June 30, 2025.
Material Changes vs. Prior Period
- Revenue: Flat quarter-over-quarter (-0.4%) and year-over-year (-0.2%). Retail revenue declined due to price compression, partially offset by higher traffic and unit sales. Wholesale revenue increased due to expanded partnerships in Maryland, Ohio, and Pennsylvania.
- Profitability: Gross margin improved to 60.6% (Q2) and 61.0% (YTD) driven by lower production costs. However, GAAP Net Loss widened to $16.1M (Q2) and $49.9M (YTD) primarily due to a significant increase in the provision for income taxes.
- Expenses: Selling, General, and Administrative (SG&A) expenses decreased slightly in Q2 but increased YTD by $16.0M, largely driven by $13.1M in campaign and political contributions.
- Liquidity: Cash and cash equivalents increased significantly to $392.6M from $238.8M at year-end 2024. Operating cash flow decreased YTD by $73.6M compared to 2024, attributed to the absence of a $59.3M tax refund received in Q1 2024 and higher political contributions.
- Tax Liability: Uncertain tax position liabilities increased by $114.4M to $559.7M, reflecting accrued interest and penalties related to the company's position on IRC Section 280E.
Guidance, Outlook, and Risks
- Outlook: Management believes existing cash balances are sufficient to meet requirements for the next 12 months. The company continues to invest in infrastructure, technology, and market expansion.
- Regulatory Risk: Cannabis remains a Schedule-I controlled substance under federal law. The company faces risks of asset forfeiture and federal enforcement actions. The company is currently under examination by taxing authorities regarding IRC Section 280E.
- Legislative Impact: The company is assessing the impact of the recently enacted "One Big Beautiful Bill Act" (H.R.1) on its financial statements.
- Contingencies: A $6.5M liability was recorded related to a lease guarantee where a tenant defaulted. Additionally, $4.5M is reserved for pending litigation claims.
- Forward-Looking Statements: The filing contains standard disclaimers regarding risks related to federal illegality, competition, and the ability to maintain licenses.
Investor Verification Checklist
- Tax Position Viability: Verify the sustainability of the $559.7M uncertain tax liability and the company's legal stance on IRC Section 280E deductions.
- Political Contributions: Review the $13.1M in campaign/political contributions included in SG&A and their impact on future operational leverage.
- Debt Maturities: Confirm the ability to service $368M in private placement notes maturing in 2026.
- Price Compression: Monitor retail pricing trends in key markets (Florida, Arizona, Pennsylvania) to assess if volume growth can offset margin pressure.
- Legislative Changes: Track the implementation details of H.R.1 and potential changes to federal cannabis regulation.